title: Lyme disease vaccination: are we ready to try again?
authors.affiliation: Department of Internal Medicine, Duke University School of Medicine, Durham, NC 27710, USA. paul.lantos@duke.edu
authors.forename: Paul M
authors.initials: PM
authors.lastname: Lantos
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000954:Antigens, Surface / Q000009:adverse effects* / Q000276:immunology*; D001425:Bacterial Outer Membrane Proteins / Q000009:adverse effects* / Q000276:immunology*; D001428:Bacterial Vaccines / Q000009:adverse effects* / Q000276:immunology*; D025065:Borrelia burgdorferi / Q000276:immunology*; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000009:adverse effects* / Q000276:immunology*; D022123:Lyme Disease Vaccines / Q000009:adverse effects* / Q000276:immunology*; D008297:Male
chemical_list: D000276:Adjuvants, Immunologic; D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D008074:Lipoproteins; D022123:Lyme Disease Vaccines; C072045:OspA protein